Insider Transactions Reported by 24 Insiders of Neurogene Inc.

Symbol
NGNE on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Neurogene Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samsara BioCapital GP, LLC 10%+ Owner $47,220,993 26 Nov 2024
Rachel McMinn Chief Executive Officer, Director $25,457,278 20 Feb 2026
Christine Mikail Cvijic President and CFO $2,329,619 -$204,702 -8.1% 13 Mar 2026
Stuart Cobb Chief Scientific Officer $673,373 -$244,449 -27% 13 Mar 2026
BAKER BROS. ADVISORS LP Director, Former 10% Owner $287,276 18 Dec 2023
Julie Jordan Chief Medical Officer $251,237 20 Feb 2026
Priti Patel Former Chief Medical Officer $25,850 31 Mar 2023
Sean Michael Smith Interim CFO, Prin Acct Off $14,990 10 Aug 2023
Jonathan G. Drachman President and CEO, Director 02 Aug 2022
Robert Ho Chief Financial Officer 01 Feb 2022
Holly Vance General Counsel 03 Aug 2021
Donna Cochener General Counsel, SVP Legal 02 Aug 2022
Erin Lavelle Director 08 Jun 2023
Erin M. Lavelle Director 11 May 2021
Martin Babler Director 08 Jun 2023
Carl Walkey Senior Vice President 02 Aug 2022
Lewis T. "rusty" Williams Director 11 May 2021
Todd E. Simpson Director 08 Jun 2023
Cory S. Freedland Director 20 Feb 2026
Robert Baffi Director 20 Feb 2026
Robert Keith Woods Director 12 Jun 2025
Sarah B. Noonberg Director 20 Feb 2026
Rohan Palekar Director 20 Feb 2026
Keith Woods Director 20 Feb 2026

Recent Insider Transactions by Companies or Individuals for Neurogene Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Stuart Cobb NGNE Common Stock Sale -18.2% $141,446 $20.81 -6,797 30,497 13 Mar 2026 Direct
Christine Mikail Cvijic NGNE Common Stock Sale -3.68% $84,176 $20.81 -4,045 105,798 13 Mar 2026 Direct
Christine Mikail Cvijic NGNE Common Stock Sale -4.19% $120,526 $25.11 -4,800 109,843 27 Feb 2026 Direct
Stuart Cobb NGNE Common Stock Award 79.4% 16,500 37,294 20 Feb 2026 Direct
Julie Jordan NGNE Common Stock Award 58.3% 4,900 13,300 20 Feb 2026 Direct
Julie Jordan NGNE Stock Option (Right to Buy) Award 29,600 29,600 20 Feb 2026 Direct
Christine Mikail Cvijic NGNE Common Stock Award 23.8% 22,000 114,643 20 Feb 2026 Direct
Christine Mikail Cvijic NGNE Stock Option (Right to Buy) Award 131,900 131,900 20 Feb 2026 Direct
Rachel McMinn NGNE Common Stock Award 1.96% 25,900 1,347,659 20 Feb 2026 Direct
Rachel McMinn NGNE Stock Option (Right to Buy) Award 155,100 155,100 20 Feb 2026 Direct
Rohan Palekar NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 20 Feb 2026 Direct
Robert Baffi NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 20 Feb 2026 Direct
Sarah B. Noonberg NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 20 Feb 2026 Direct
Cory S. Freedland NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 20 Feb 2026 Direct
Keith Woods NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 20 Feb 2026 Direct
Robert Baffi NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 12 Jun 2025 Direct
Robert Keith Woods NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 12 Jun 2025 Direct
Rohan Palekar NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 12 Jun 2025 Direct
Cory S. Freedland NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 12 Jun 2025 Direct
Sarah B. Noonberg NGNE Non-Qualified Stock Option (right to buy) Award 12,050 12,050 12 Jun 2025 Direct
Stuart Cobb NGNE Common Stock Sale -24.6% $103,003 $15.15 -6,797 20,794 14 May 2025 Direct
Stuart Cobb NGNE Common Stock Award 35.3% 7,200 27,591 26 Mar 2025 Direct
Stuart Cobb NGNE Employee Stock Option (Right to buy) Award 42,900 42,900 26 Mar 2025 Direct
Christine Mikail Cvijic NGNE Common Stock Award 28.1% 20,300 92,643 26 Mar 2025 Direct
Christine Mikail Cvijic NGNE Employee Stock Option (Right to buy) Award 122,000 122,000 26 Mar 2025 Direct
Julie Jordan NGNE Common Stock Award 8,400 8,400 26 Mar 2025 Direct
Julie Jordan NGNE Employee Stock Option (Right to buy) Award 50,300 50,300 26 Mar 2025 Direct
Rachel McMinn NGNE Common Stock Award 1.91% 23,900 1,274,259 26 Mar 2025 Direct
Rachel McMinn NGNE Employee Stock Option (Right to buy) Award 143,500 143,500 26 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.